TANG CAPITAL MANAGEMENT LLC Q2 2018 Filing

Filed August 14, 2018

Portfolio Value

$789.0B

Holdings

4

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (4 positions)

#StockSharesValue% PortfolioType
1
HRTXHERON THERAPEUTICS INC
8,647,398$336.0B42.58%
2
—ODONATE THERAPEUTICS INC
12,412,338$274.1B34.74%
3
—LA JOLLA PHARMACEUTICAL CO
4,138,893$120.7B15.30%
4
RCKTROCKET PHARMACEUTICALS INC
2,965,485$58.2B7.38%